Posts by: Daniela Semedo, PhD

Daniela Semedo, PhD

Daniela holds a PhD in Clinical Psychology from The University of Edinburgh, United Kingdom, a MSc in Health Psychology and a BSc in Clinical Psychology. Her work has been focused on vulnerability to psychopathology and early identification and intervention in psychosis.

February 15, 2017February 15, 2017

EMA Reviewing Safety of Uptravi After 5 Deaths Reported in PAH Patients in France

News, Pulmonary Hypertension

The European Medicines Agency (EMA) is re-examining the safety of Uptravi (selexipag) after five pulmonary arterial hypertension (PAH) patients in France died while taking the medicine, the agency announced in a ... Read more

February 9, 2017February 9, 2017

SmartVest Airway Clearance System Cuts Bronchiectasis Healthcare Costs, Study Says

Bronchiectasis, News

Electromed’s SmartVest Airway Clearance System can substantially reduce the healthcare services that bronchiectasis patients need, saving them $3,045 annually, a study says. The research, “Cost-Effective Analysis of Using High Frequency Chest Wall ... Read more

February 7, 2017February 7, 2017

Children with Asthma Four Times More Likely to Have Kidney Stones, Study Shows

Asthma, News

Children with asthma are four times more likely to have kidney stones than children without asthma, Cleveland Clinic researchers found. The study, “Co-Occurrence of Asthma and Nephrolithiasis in Children,” was ... Read more

February 6, 2017February 6, 2017

International Experts Update Guidelines for Cystic Fibrosis Diagnosis

Cystic Fibrosis, News

An international group of experts has updated the guidelines for the definite diagnosis of cystic fibrosis (CF), which will help clinicians make a correct diagnoses and offer personalized therapies to their ... Read more

February 2, 2017February 2, 2017

Reduced Infant Lung Function an Indicator of Chronic Asthma in Young Adults, Study Shows

Asthma, News

Reduced lung function in infants points to chronic asthma in young adults, according to a recent study. The findings suggest that asthma may be caused by abnormal lung development and growth ... Read more

January 24, 2017January 24, 2017

FDA Grants Orphan Drug Status to Concert’s Cystic Fibrosis Therapy Candidate

Cystic Fibrosis, News

The U.S. Food and Drug Administration (FDA) has granted Orphan Drug designation to Concert Pharmaceuticals’ CTP-656 (deuterium-modified ivacaftor), a next generation CFTR (cystic fibrosis transmembrane conductance regulator) potentiator which is being developed for ... Read more

January 20, 2017January 20, 2017

PhaseBio’s $14.7M in Financing to Advance Therapy for PAH, Other Cardiopulmonary Disorders

News, Pulmonary Hypertension

PhaseBio Pharmaceuticals has closed on $14.7 million in financing to advance PB1046, its lead compound in clinical development, as a potential treatment of orphan cardiopulmonary disorders such as pulmonary arterial ... Read more

January 17, 2017January 17, 2017

UK Inhaler Group to Present Data on Inhaled Therapies at Upcoming London Conference

Asthma, COPD, News

Key inhaler information, including compliance by patients with asthma and chronic obstructive pulmonary disease (COPD), along with educating patients and healthcare professionals (HCPs), will be one of the highlights of ... Read more

January 16, 2017January 16, 2017

Strategies Needed to Improve Adherence to COPD Medications, Study Says

COPD, News

Humana and Boehringer Ingelheim Pharmaceuticals have published a study showing that non-adherence to chronic obstructive pulmonary disease (COPD) medications is linked to non-adherence to medications for other chronic diseases. The ... Read more

January 12, 2017January 12, 2017

CFF Therapeutics Awards Aridis Grant to Advance Therapy for Lung Infections

Cystic Fibrosis, News

Cystic Fibrosis Foundation Therapeutics (CFFT), the drug discovery and development affiliate of the Cystic Fibrosis Foundation (CFF), has awarded Aridis Pharmaceuticals a grant to support the clinical development of Panaecin (gallium ... Read more